Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sam Schulman

Showing results (271-280 of 308) with videos related to

Pageof 31
Sort By:
The Lancet. Haematology|September 19, 2025
Sustainable anticoagulation for climate resilient careBingwen Eugene Fan, Kevin Milla, Scott McAlister, et al.
European Heart Journal|July 13, 2023
Management of patients on antithrombotic therapy with severe infections: a joint clinical consensus statement of the ESC Working Group on Thrombosis, the ESC Working Group on Atherosclerosis and Vascular Biology, and the International Society on Thrombosis and HaemostasisBruna Gigante, Jerrold H Levy, Eric van Gorp, et al.
Annals of Internal Medicine|January 7, 2015
D-dimer testing to select patients with a first unprovoked venous thromboembolism who can stop anticoagulant therapy: a cohort studyClive Kearon, Frederick A Spencer, Denis O'Keeffe, et al.
Journal of Thrombosis and Haemostasis : JTH|October 26, 2024
Duration of anticoagulation for venous thromboembolism in pediatric patients: Evaluation of the Duration of Therapy for Thrombosis in Children (Kids-DOTT) trial outcomes at 2 yearsNeil A Goldenberg, Sam Schulman, John M Kittelson, et al.
Journal of Thrombosis and Haemostasis : JTH|March 12, 2023
Clinical course and treatment of incidentally detected splanchnic vein thrombosis: an individual patient data meta-analysisMatteo Candeloro, Emanuele Valeriani, Manuel Monreal, et al.
BMJ Open|May 1, 2024
Coordination of oral anticoagulant care at hospital discharge (COACHeD): pilot randomised controlled trialAnne Holbrook, Sue Troyan, Victoria Telford, et al.
JAMA|January 11, 2022
Effect of Anticoagulant Therapy for 6 Weeks vs 3 Months on Recurrence and Bleeding Events in Patients Younger Than 21 Years of Age With Provoked Venous Thromboembolism: The Kids-DOTT Randomized Clinical TrialNeil A Goldenberg, John M Kittelson, Thomas C Abshire, et al.
Neurology|July 21, 2017
Long-term antithrombotic treatment in intracranial hemorrhage survivors with atrial fibrillationEleni Korompoki, Filippos T Filippidis, Peter B Nielsen, et al.
Journal of Thrombosis and Haemostasis : JTH|March 19, 2024
2023 ISTH update of the 2022 ISTH guidelines for antithrombotic treatment in COVID-19Sam Schulman, Donald M Arnold, Charlotte A Bradbury, et al.
Thrombosis and Haemostasis|May 12, 2010
Oral vitamin K effectively treats international normalised ratio (INR) values in excess of 10. Results of a prospective cohort studyMark A Crowther, David Garcia, Walter Ageno, et al.
Pageof 31

Showing results (271-280 of 308) with videos related to

Sort By:
Pageof 31
The Lancet. Haematology|September 19, 2025
Sustainable anticoagulation for climate resilient careBingwen Eugene Fan, Kevin Milla, Scott McAlister, et al.
European Heart Journal|July 13, 2023
Management of patients on antithrombotic therapy with severe infections: a joint clinical consensus statement of the ESC Working Group on Thrombosis, the ESC Working Group on Atherosclerosis and Vascular Biology, and the International Society on Thrombosis and HaemostasisBruna Gigante, Jerrold H Levy, Eric van Gorp, et al.
Annals of Internal Medicine|January 7, 2015
D-dimer testing to select patients with a first unprovoked venous thromboembolism who can stop anticoagulant therapy: a cohort studyClive Kearon, Frederick A Spencer, Denis O'Keeffe, et al.
Journal of Thrombosis and Haemostasis : JTH|October 26, 2024
Duration of anticoagulation for venous thromboembolism in pediatric patients: Evaluation of the Duration of Therapy for Thrombosis in Children (Kids-DOTT) trial outcomes at 2 yearsNeil A Goldenberg, Sam Schulman, John M Kittelson, et al.
Journal of Thrombosis and Haemostasis : JTH|March 12, 2023
Clinical course and treatment of incidentally detected splanchnic vein thrombosis: an individual patient data meta-analysisMatteo Candeloro, Emanuele Valeriani, Manuel Monreal, et al.
BMJ Open|May 1, 2024
Coordination of oral anticoagulant care at hospital discharge (COACHeD): pilot randomised controlled trialAnne Holbrook, Sue Troyan, Victoria Telford, et al.
JAMA|January 11, 2022
Effect of Anticoagulant Therapy for 6 Weeks vs 3 Months on Recurrence and Bleeding Events in Patients Younger Than 21 Years of Age With Provoked Venous Thromboembolism: The Kids-DOTT Randomized Clinical TrialNeil A Goldenberg, John M Kittelson, Thomas C Abshire, et al.
Neurology|July 21, 2017
Long-term antithrombotic treatment in intracranial hemorrhage survivors with atrial fibrillationEleni Korompoki, Filippos T Filippidis, Peter B Nielsen, et al.
Journal of Thrombosis and Haemostasis : JTH|March 19, 2024
2023 ISTH update of the 2022 ISTH guidelines for antithrombotic treatment in COVID-19Sam Schulman, Donald M Arnold, Charlotte A Bradbury, et al.
Thrombosis and Haemostasis|May 12, 2010
Oral vitamin K effectively treats international normalised ratio (INR) values in excess of 10. Results of a prospective cohort studyMark A Crowther, David Garcia, Walter Ageno, et al.
Pageof 31